Epigenomics AG (FRA:ECX)

Germany flag Germany · Delayed Price · Currency is EUR
0.9200
+0.0200 (2.22%)
Last updated: Jan 9, 2026, 2:12 PM CET
-42.50%
Market Cap789.25K
Revenue (ttm)4.00K
Net Income (ttm)-2.76M
Shares Out876.95K
EPS (ttm)-3.15
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume419
Average Volume459
Open0.9000
Previous Close0.9000
Day's Range0.9000 - 1.0000
52-Week Range0.5000 - 1.7000
Beta0.82
RSI51.04
Earnings DateMar 24, 2026

About Epigenomics AG

Epigenomics AG does not have significant operations. Previously, the company was involved in liquid biopsy for the early detection of cancer. The company was founded in 1998 and is headquartered in Heidelberg, Germany. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 1998
Employees 2
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol ECX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.